Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Open in API
Filings indexed 969 across all filing types
Latest filing 2021-05-12 Interim / Quarterly Rep…
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q1 2021
2021-05-12 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 12, 2021, reporting the results of operations for the first fiscal quarter ended March 31, 2021. It specifically mentions an attached earnings press release (Exhibit 99.1) reporting the financial results. The text indicates this is an initial announcement of quarterly financial results, which aligns with the definition of an Earnings Release (ER). The document length is 3535 characters, which is relatively short but contains the actual earnings release information rather than just a notice of publication. Therefore, the classification is Earnings Release (ER).
2021-05-12 English
10-K
Annual Report FY 2020
2021-03-31 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 31, 2021, reporting the results of operations for the fourth fiscal quarter ended December 31, 2020. It specifically mentions an attached earnings press release (Exhibit 99.1) reporting the financial results. The content and context indicate this is an initial announcement of quarterly financial results, which aligns with the definition of an Earnings Release (ER). The document length is 3546 characters, which is consistent with a brief earnings announcement rather than a full financial report. Therefore, the appropriate classification is Earnings Release (ER).
2021-03-31 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 25, 2021, reporting an increase in the base annual cash compensation for the Chair of the Audit Committee and non-employee board members. The content focuses on changes in board compensation, which is a management/board-related announcement. The document is relatively short (3400 characters) and does not contain financial statements or detailed financial data. It is not an annual or quarterly report, nor an earnings release or audit report. The primary subject is changes in board compensation, which falls under Board/Management Information (MANG).
2021-03-30 English
FORM 4
Director's Dealing
2021-03-08 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.